Now You Can Help Make the Alethus 2.0 Device a Reality
Pilot Clinical Trial to be Conducted Following a Protocol Under the IDE (Investigational Device Exemption, FDA) at a Leading Institution
Confirmation Product Works Across Full Range
FDA Approval Process
Manufacturing and Marketing of Devices
We are currently raising funds for the development of our 2.0 device to demonstrate high accuracy across the physiological range of insulin secretion and concentration. This 2.0 device will be used in a pilot clinic trial and pave the development path towards our pivotal trials.
If you are an Accredited Investor as defined by the Securities and Exchange Commission (SEC) under Regulation D (refers to investors who are financially sophisticated and have a reduced need for the protection provided by certain government filings), would be interested in investing a minimum of $10,000, and would like to learn more about investing in Alethus, Seed B Preferred Financing, please click on one of the links below: